Advanced Filters
noise

Lorenskog, Norway Clinical Trials

A listing of Lorenskog, Norway clinical trials actively recruiting patients volunteers.

Found 335 clinical trials

FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

FaR-RMS is an over-arching study for children and adults with newly diagnosed and relapsed rhabdomyosarcoma (RMS)

- 100 years of age Both Phase 1/2
M Maria Romøren

Advanced Care Planning for the Severely Ill Home-dwelling Elderly

This study will develop and evaluate a complex intervention to implement advance care planning for severely ill home-dwelling elderly acutely admitted to hospital, by using a cluster randomized design. Twelve Norwegian acute geriatric hospital units will participate in the main study, each as one cluster. Of the twelve clusters, half …

70 - 100 years of age Both Phase N/A
H Hanna C Björnsson Hallgren, MD, PhD

ACCURATE Trial - Operative Treatment of Acute Rotator Cuff Tear Related to Trauma

Rotator cuff tear is a very common and disabling condition that can be related to acute trauma such as falling on the shoulder. A tear is associated with symptoms such as pain in abduction, abduction weakness and night pain. Rotator cuff tear surgery is a well-established form of treatment in …

45 - 70 years of age Both Phase N/A
C Camilla Styffe Sæland, Master

Quality of Life and Gut Health in Pediatric Patients With Cystic Fibrosis

The aim of the present study is to investigate the effect of probiotic supplementation on GI related quality of life, through a randomised placebo-controlled clinical trial. Moreover, the invetigators wish to study CF microbiota and intestinal inflammation in the setting of probiotic supplementation and newly started treatment with a highly …

2 - 18 years of age Both Phase N/A
K Karsten Midtvedt, MD, PhD

Home Based Monitoring of Kidney Transplants Utilizing Capillary Microsamples

Renal transplant recipients are followed as out patients at the transplant center for about 8 weeks after surgery. Between 1-2 weeks after surgery, 50 standard immunological patients will be randomized (1:1) to either follow standard of care (SOC) or having every second poli clinical visit without entering the hospital HBM; …

18 - 100 years of age Both Phase N/A
H Harald Hrubos-Strøm, PhD

The Effect of Orofacial Myofunctional Therapy With Autofeedback on Obstructive Sleep Apnea

The overall aim of this study is to estimate the effect of orofacial myofunctional therapy (OMT) plus auto-monitoring compared to auto-monitoring alone. Moreover, the investigators aim to identify anatomical and behavioural predictors of OMT adherence

18 - 100 years of age Both Phase N/A
P Per-Henrik Randsborg, PhD MD

Two- Part Proximal Humerus - Conservative vs Operative

The proximal humerus fracture (PHFs) is the third most common fracture type in the elderly, and represents 5% of the overall fractures. The incidence is increasing. The purpose of the project is to compare surgical and conservative management of two- part PHFs in light of radiological, economical and clinical outcome. …

60 - 85 years of age Both Phase N/A
H Hanne Fuglø, MSc

Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?

The goal of this clinical trial is to compare two different types of reverse shoulder replacements. Researchers will compare a conventional reverse shoulder replacement with a lateralized reverse shoulder replacement to see if there is a difference in how well the patients function after two years.

45 - 80 years of age Both Phase N/A
F Fredrik Nilsen, MD

Osteosynthesis of Intraarticular Calcaneal Fractures: Arthroscopically Assisted Percutaneous Technique Versus Sinus Tarsi Approach

In this randomized controlled trial, the outcomes of two surgical techniques for intraarticular calcaneal fractures will be evaluated and compared.

18 - 70 years of age Both Phase N/A

Precision Therapy Versus Standard Therapy in AML and MDS in Elderly

This is a randomized clinical trial that randomizes between treatment principles. The study will investigate if precision therapy determined by a tumour board is better than standard treatment for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) in elderly. The tumour board will decide the precision therapy based on identified …

60 - 100 years of age Both Phase 2

Rewrite in simple language using AI